May 28, 2012 Issue | Chemical & Engineering News
 
 
 
Copyright © 2012 American Chemical Society
 

May 28, 2012 Issue

Volume 90, Issue 22
09022-cover1-MAON401cxd
May 28, 2012 Issue, Vol. 90 | Iss. 22
As pharmaceutical manufacturers increasingly use enzymatic reactions in their processes, a robust business model still eludes biocatalysis companies
By Ann M. Thayer
(pp. 13-18)
Features
Government & Policy
Chemical firms take their beef over rates and service to a transportation board (pp. 37-40)
Science & Technology
Concerns grow over nanoparticle characterization and purity (pp. 48-50)
Back Issues
 

Cover Story: Biocatalysis

Pharma Strives For Green Goals
Technology and metrics are major factors in drug firms’ approaches to reducing waste
(pp. 20-24)
 

News of the Week

Leaders Set Mix Of Goals

International: G-8 Summit discussions include energy, climate, and agriculture
(p.7)

A Step Forward For Quantum Dots

Nanomedicine: Researchers see no negative health effects of the tiny particles in monkeys
(p.8)

DSM Will Acquire Ocean Nutrition

Supplements: Purchase advances chemical company’s position in omega-3 fatty acids
(p.8)

Cracker Builders Unite

France's Technip is acquiring Stone & Webster from Shaw Group
(p.9)

Nanocrystal Growth Observed

Imaging: Using electron microscopy, researchers reveal mechanism of nanoparticle fusion
(p.9)

Jaczko Heads For The Exit

Government: Embattled NRC chairman says he is stepping down
(p.10)

Single Molecule Channels Water

Nanotechnology: Molecular tube transports water across lipid membrane
(p.10)

Changing Science Teaching

Education: Students learn better from interactive methods, report says
(p.11)

Surface Do-Overs

Photochemistry: Rapid reaction attaches protein or dyes
(p.11)
 

Departments

09022-bus2-RPLabbayscxd

Business

Exit of a major supplier has lab chemical makers scrambling
(pp. 30-32)
Claims and counterclaims obscure truth in case pitting U.S. resin maker against Chinese rival
(pp. 28-29)
Clinical experience will bring focus to the data surge of genomics
(p.34)
As pharmaceutical manufacturers increasingly use enzymatic reactions in their processes, a robust business model still eludes biocatalysis companies
(pp. 13-18)
Technology and metrics are major factors in drug firms’ approaches to reducing waste
(pp. 20-24)

ACS News

ACS members take on Capitol Hill to lobby for more federal support for research
(p.55)

Government & Policy

NIH initiative aims to partner academics with pharmaceutical companies to revive failed drug candidates
(pp. 41-43)
Chemical firms take their beef over rates and service to a transportation board
(pp. 37-40)
EPA wants some information submitted for REACH, but companies say they can’t share the information
(pp. 44-45)

Education

Proposed framework for K–12 education aims for depth over breadth
(p.54)